Stereotaxis is trading at $1.32, down -5.36%, with no clear catalyst identified.

  • No company press release or major announcement was listed for September 23, 2026; the latest release was September 16, 2026.
  • Broader market weakness was limited: the Dow fell 0.4%, the S&P 500 was marginally lower, while technology gained.
  • Trading-specific pressure or delayed news may have contributed, but causation remains unconfirmed.